Achieve Life Sciences, Inc.
ACHV
$6.72
$0.050.75%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
MarketBeat
8/11/2026
-
The Cerbat Gem
8/11/2026
-
MarketBeat
8/11/2026
-
TipRanks: TheFly
8/11/2026
-
SeekingAlpha.com: All News
8/11/2026
-
MarketBeat
8/9/2026
-
TipRanks
8/8/2026
-
TipRanks
Achieve Life Sciences (ACHV, $6.66) price may drop as it broke higher Bollinger Band on Aug 05, 2026
8/6/2026
-
Tickeron - Stocks
8/4/2026
-
TipRanks: TheFly
8/3/2026
-
Globe Newswire
8/2/2026
-
MarketBeat
7/31/2026
-
Globe Newswire
7/30/2026
-
Tickeron - Stocks
7/26/2026
-
The Cerbat Gem
7/25/2026
-
MarketBeat
7/24/2026
-
Tickeron - Stocks
7/17/2026
-
MarketBeat
7/16/2026
-
Tickeron - Stocks
7/14/2026
-
Tickeron - Stocks
7/10/2026
-
The Cerbat Gem
7/10/2026
-
MarketBeat
7/10/2026
-
MarketBeat
7/7/2026
-
Seeking Alpha: Editor's Picks
7/7/2026
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
604 210 2217
Address
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
Suite 100
Bothell, WA 98021
Country
Year Founded
--
Business Description
Sector
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The...
more